JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) Short Interest Up 100.0% in January

JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) was the target of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 200 shares, an increase of 100.0% from the December 31st total of 100 shares. Based on an average daily trading volume, of 500 shares, the days-to-cover ratio is currently 0.4 days.

JPMorgan Healthcare Leaders ETF Trading Down 0.5 %

Shares of JDOC traded down $0.29 on Friday, reaching $54.48. 966 shares of the company’s stock traded hands, compared to its average volume of 643. The stock has a market cap of $8.17 million, a PE ratio of 27.37 and a beta of 0.61. The stock’s 50 day simple moving average is $53.50 and its two-hundred day simple moving average is $57.81. JPMorgan Healthcare Leaders ETF has a 52-week low of $50.54 and a 52-week high of $63.49.

JPMorgan Healthcare Leaders ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 27th. Shareholders of record on Tuesday, December 24th were issued a dividend of $0.3276 per share. The ex-dividend date was Tuesday, December 24th.

Hedge Funds Weigh In On JPMorgan Healthcare Leaders ETF

An institutional investor recently bought a new position in JPMorgan Healthcare Leaders ETF stock. Krilogy Financial LLC acquired a new position in JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 10,212 shares of the company’s stock, valued at approximately $517,000. Krilogy Financial LLC owned approximately 6.81% of JPMorgan Healthcare Leaders ETF as of its most recent filing with the Securities & Exchange Commission.

JPMorgan Healthcare Leaders ETF Company Profile

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation.